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Abstract: Acetylenic amine derivatives of the 5,8-quinolinedione were synthesized and
characterized by the 1H and 13C NMR, IR spectroscopy and MS spectra. Additionally, the 6-
and 7-substituted allylamine-5,8-quinolinediones were synthesized for comparison purposes.
The crystal structure was determined for the 6-chloro-7-propargylamine-5,8-quinolinedione and
7-chloro-6-propargylamine-5,8-quinolinedione. Additionally, the IR spectral analysis supplemented
by the density functional theory (DFT) calculations were carried out. It was found that different
positions of the propargylamine side chain had a distinct influence on crystal structure, formation of
H-bonds and the carbonyl stretching IR bands. Correlation between the frequency separation ∆ν
of the carbonyl IR bands and the position of the 6- and 7-substituents was found. The 7-substituted
derivatives exhibited a higher frequency separation ∆ν. The observed correlation could provide
an opportunity to use the IR spectroscopy to study substitution reactions. Cytotoxic activities against
three human cancer cell lines for the 5,8-quinolinedione derivatives with different amine substituents,
i.e., propargylamine, N-methylpropargylamine, 1,1-dimethylpropargylamine, allylamine and
propylamine were also analysed with respect to their molecular structure.
Keywords: propargylamine-5,8-quinolinediones; crystal structure; H-bonding; IR carbonyl bands
1. Introduction
The 5,8-quinolinedione derivatives were among the first compounds to be systematically modified
in order to find products with higher biological activities, such as anticancer, anti-inflammatory or
antibacterial [1–9]. For example, it was found that substitution of the electron-withdrawing groups at
the 6- or 7-positions of the 5,8-quinolinedione led to an increase in the DNA degradation [8–13].
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There are many reports on the synthesis, structure and biological activity of the amine derivatives
of 5,8-quinolinedione, whereas studies on the alkyne amino analogues are very scarce [14]. Natural and
synthetic acetylenic derivatives of the quinoline attract increasing attention since many of them display
wide biological activity spectra [15–22]. According to the literature data, introduction of the alkyne
group may significantly improve biological activity of these compounds [21,22].
In this study, we present synthesis and antiproliferative activity of the series of acetylenic amino
derivatives of the 5,8-quinolinedione. Moreover, the structural properties of two acetylenic compounds,
i.e., 6-chloro-7-propargylamine-5,8-quinolinedione and7-chloro-6-propargylamine-5,8-quinolinedione
were determined by X-ray diffraction and IR spectroscopy.
Our attention was also focused on the carbonyl stretching bands in the infrared spectra of
the propargylamine-substituted 5,8-quinolinedione, which are known as bands very sensitive to
morphology. For para-quinones, one or two carbonyl bands can be observed. This feature can be
influenced by many factors: mainly intra- and intermolecular interactions and conformational
changes [23,24]. It can create the opportunity for additional structural investigations using IR
carbonyl bands. For example, we recently found an interesting correlation between the frequency
separation of carbonyl bands and the position of propylamine substituents on 5,8-quinolinediones [25].
Therefore, in this report we also aimed to check whether a similar correlation exists for
the propargylamine-substituted 5,8-quinolinediones.
2. Results and Discussion
2.1. Chemistry
The 6,7-dichloro-5,8-quinolinedione 1 was prepared by the oxidation of the 8-hydroxyquinoline [12]
and used as a starting compound for the synthesis of the acetylenic derivatives 2–3 using procedures
described in the literature [8,9,25]. Treatment of compound 1 with the corresponding amine in
tetrahydrofuran in the presence of potassium carbonate at room temperature gave a mixture of 7- and
6-aminosubstituted derivatives, 2a–e and 3a–e, respectively (Scheme 1).
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Scheme 1. Synthesis of the 6-chloro-7-substituted 5,8-quinolinediones 2a–e and 7-chloro-6-
substituted 5,8-quinolinediones 3a–e. 
The obtained mixtures were separated by column chromatography to afford pure products  
2a–e and 3a–e with the 68%–58% and 16%–21% yields, respectively. The structures of all derivatives 
2–3 were determined by the 1H, 13C NMR, IR and MS spectra. 
For both isomeric compounds 2 and 3 the 1H NMR chemical shifts were similar, and therefore it 
was not possible to distinguish between 6- and 7-substituents based on the spectra (see Figure S1–S8 
in supplement material). According to the literature data [8,12], such differentiation is possible when 
using the 13C NMR spectra. It was found that the isomers 2 and 3 showed different signal intensities 
of the C-5, C-8, C-6 and C-7 atoms. For the 6-aminosubstituted derivatives, the signal intensities of 
the C-5 and C-7 atoms were higher than those for the C-8 and C-6 atoms. For the 7-aminosubstituted 
derivatives, the signal intensities followed the opposite relation, i.e., they were higher for the C-8 and 
C-6 atoms. Therefore, it was confirmed that compounds 2 and 3 possessed the amine group at the C-
7 and C-6 positions, respectively. Additionally, for derivatives 2a and 3a, the X-ray diffraction 
analysis confirmed also substitution of the propargylamine chain at the C-7 and C-6 positions, 
respectively. 
Scheme 1. Synthesis of the 6-chloro-7-substituted 5,8-quinolinediones 2a–e and 7-chloro-6-substituted
5,8-quinolinediones 3a–e.
The obtained mixtures were separated by column chromatography to afford pure products 2a–e
and 3a–e with the 68%–58% and 16%–21% yields, respectively. The structures of all derivatives 2–3
were determined by the 1H, 13C NMR, IR and MS spectra.
For both isomeric compounds 2 and 3 the 1H NMR chemical shifts were similar, and therefore it
was not possible to distinguish between 6- and 7-substituents based on the spectra (see Figure S1–S8 in
supplement material). According to the literature data [8,12], such differentiation is possible when
using the 13C NMR spectra. It was found that the isomers 2 and 3 showed different signal intensities
of the C-5, C-8, C-6 and C-7 atoms. For the 6-aminosubstituted derivatives, the signal intensities of
the C-5 and C-7 atoms were higher than those for the C-8 and C-6 atoms. For the 7-aminosubstituted
derivatives, the signal intensities followed the opposite relation, i.e., they were higher for the C-8 and
C-6 atoms. Therefore, it was confirmed that compounds 2 and 3 possessed the amine group at the C-7
and C-6 positions, respectively. Additionally, for derivatives 2a and 3a, the X-ray diffraction analysis
confirmed also substitution of the propargylamine chain at the C-7 and C-6 positions, respectively.
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2.2. Crystal Structure and Formation of Hydrogen Bonds
The 6-chloro-7-propargylamine-5,8-quinolinedione 2a and 7-chloro-6-propargylamine-5,8-
quinolinedione 3a crystallized in two different monocyclic space groups, i.e., Pc and P21/n, respectively.
Figure 1 shows molecular structures and atom numbers of the compounds 2a and 3a. In Table 1,
the crystal parameters, experimental data and refinement details are shown.
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Figure 1. Molecular structures with atom numbering of (a) 6-chloro-7-propargylamine-5,8-
quinolinedione 2a; (b) 7-chloro-6-propargylamine-5,8-quinolinedione 3a.
Table 1. Crystal parameters, data collection and refinement details for compounds 2a and 3a.
Parameter 2a 3a
Chemical formula C12H7ClN2O2 C12H7ClN2O2
Mr 246.65
Crystal system, space group Monoclinic, Pc Monoclinic, P21/n
Temperature (K) 100
a, b, c (Å) 4.0250 (12), 6.5937 (6), 19.3214 (13) 11.1550 (3), 7.9114 (2), 12.0047 (3)
β (◦) 90.673 (12) 97.554 (3)
V (Å3) 512.75 (16) 1050.24 (5)
Z 2 4
Radiation type Mo Kα
µ (mm−1) 0.36 0.35
Crystal size (mm) 0.38 × 0.05 × 0.04 0.56 × 0.22 × 0.03
Diffractometer Oxford Diffraction diffractometer with Sapphire3 detector
Absorption correction
Multi-sca CrysAlis RED, Oxford Diffraction Ltd., Version 1.171.32.29
Empirical absorption correction using spherical harmonics, implemented in
SCALE3 ABSPACK scaling algorithm.
Tmin, Tmax 0.875, 0.984 0.911, 1.000
N . of measured, independent
and observed [I > 2σ(I)] reflections
3745,
1261,
1144
7654,
1995,
1657
Rint 0.036 0.026
(sin θ/λ)max (Å−1) 0.609 0.610
R[F2 > 2σ(F2)], wR(F2), S 0.032, 0.078, 1.00 0.027, 0.072, 1.03
No. of reflections 1261 1995
No. of parameters 164 160
No. of restraints 2 -
H-atom treatment H atoms treated by a mixture of independent and constrained refinement
(∆)max, (∆)min ( Å−3) 0.61, −0.25 0.30, −0.20
Absolute structure Refined as an inversion twin. -
Absolute structure parameter 0.95 (14) -
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The selected values of bond distances and angles are presented in Table S1 (supplement material).
In terms of bond distances and angles, the geometry of molecules 2a and 3a shows typical values [23,25].
These are in good agreement with the calculated values. The observed discrepancies between
experimental and calculated values are mainly due to the method of calculations. They were done
for a single molecule in a vacuum, which means that intermolecular interactions were not taken
into account.
The unit cell of 2a contains two molecules (Z = 2). The 5,8-quinolinedione rings accomplish
a planar structure. In the unit cell these planes are arranged parallel to each other (see Figure S9 in
supplement material). An angle between plane of rings and the propargylamine chain N2C9C10C11 is
equal to 84.77◦. This conformation is very similar to that which occurred for the corresponding angle
in the crystal structure of the 6-chloro-7-propylamine-5,8-quinolinedione (89.77◦) described earlier
by Jastrzebska et al. [25]. Figure 2 depicts the hydrogen bonds found in the crystal structure of 2a.
In Table 2 parameters of the hydrogen bonds for 2a are collected.
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Table 2. Para eters ( , egree) of the hydrogen bonds for co pounds 2a and 3a.
D–H···A D–H H···A D···A <D–H···A
6-chloro-7-propargylamine-5,8-quinolinedione 2a
C4–H4···O2 0.95 (1) 2.373 (4) 3.219 (4) 148.1
N2–H2N···O1 0.83 (1) 2.403 (4) 3.015 (4) 131.2
C9–H9A···O1 0.83 (2) 2.629 (2) 3.207 (2) 127.9
C11–H11···N1 0.95 (1) 2.300 (2) 3.158 (3) 149.9
7-chloro-6-propargylamine-5,8-quinolinedione 3a
N2–H2N···N1 0.85 (1) 2.181 (1) 2.957 (1) 152.5
C11–H11···O2 0.95 (1) 2.338 (2) 3.282 (1) 172.2
Both carbonyl groups of 2a participate in the formation of hydrogen bonds. The oxygen atom O1
forms the bifurcated hydrogen bond, which can be described as: N2–H2N···O1···H9A–C9 (Figure 2).
Two other short hydrogen bonds C11–H11···N1 and C4–H4···O2 have also been found in 2a with
the H···A distances equal to 2.373 and 2.300 Å, respectively (Table 3). According to the literature
data [26,27], for the hydrogen bonds from the acidic C–H donors in the C≡C–H to the N acceptors,
the mean H···N distance is reported to be 2.40 Å. The reason for the shorter H···N distance in 2a might
be the higher basicity of the pyridyl N atom.
For the 7-chloro-6-propargylamine-5,8-quinolinedione 3a, the crystal unit cell contains
four molecules (Z = 4, Table 1). The molecules form two layers with the 5,8-quinolinedione rings located
inside the unit (see Figure S10 in supplement material). An angle between the 5,8-quinolinedione rings’
plane and the propargylamine chain is equal to 68.57◦ and is significantly smaller than that for 2a
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(84.77◦). Simultaneously, this angle is very similar to the corresponding angle in the crystal structure of
the 7-chloro-6-propylamine-5,8-quinolinedione 3e (68.57◦), which was described earlier [25]. Figure 3
shows the unit cell and the hydrogen bonds identified in the crystal structure of 3a. All parameters of
the H-bonds seen in Figure 3 are summarized in Table 2.Crystals 2017, 7, 15  5 of 14 
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For 3a crystal structure, the inter- and intra-molecular hydrogen bonds C11–H11···O1 and
N2–H2N···N1 are observed, respectively. The N···N distance between the donor and acceptor nitrogen
nuclei for the 3a and 3e are equal to 2.957 Å and 3.151 Å, respectively [25]. This pronounced difference
could be explained by the higher basicity of the N–H donor group from the propargylamine chain in
comparison to that from the propylamine.
2.3. IR Spectra
Analysis of the IR spectral bands, especially in the frequency ranges of the carbonyl and
amine stretching vibrations, have been performed using the calculated harmonic vibrational spectra.
Comparison of the experimental and the density functional theory (DFT)-calculated spectra allowed
also to obtain information about an impact of the H-bond formation on the vibrational bands, e.g.,
νstr(N–H), νstr(C=O) or νstr(C≡C–H).
In Figures 4 and 5, the IR spectra for compounds 2a and 3a, both experimental and calculated,
are presented. Assignments of the selected bands for all spectra are shown in Table 3.
As shown in Figures 4 and 5, the calculated spectra well reproduce these experimental. This also
gives good agreement between calculated and experimental frequencies, which can be seen in Table 3.
The observed differences are mainly due to the fact that we are comparing the theoretical spectra of
a single molecule in a vacuum with the experimental spectra of crystalline substance.
At lower wavenumbers, i.e., below 1300 cm−1, the observed bands are mainly assigned to
the aromatic C–C and C–H vibrations. One can also observe the C–C and C≡C–H aliphatic bend
vibrations near 580–590 cm−1 and 650–660 cm−1, respectively. For compound 2a the band at 1427 cm−1
is assigned to the C–H aliphatic stretching vibrations. As is seen in Figure 4a, its experimental and
calculated band intensities show significant difference. The higher intensity of the experimental
band is due to formation of the hydrogen bond C9–H9A···O1. According to literature data [26–28],
the enhancement of the band intensity for the stretching vibrations of the X–H group (H-bond donor
group) is associated with the exceptionally great variation of the electric dipole moment of X–H···Y.
This enhancement of intensity is sometimes used to extract information on H-bond [28].
Crystals 2017, 7, 15 6 of 14
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Table 3. Experimental and calculated vibrational frequencies (cm−1) and band assignments for studied
compounds 2a and 3a.
Experimental Calculated Assignment
6-chloro-7-propargylamine-5,8-quinolinedione 2a
581 579 C–C aliphatic bend
652 650 C≡C–H bend
748–696 723–689 C–C ring stretch, C–H ring stretch
826–8 8 803 C–Cl bend
1153–1139 1175–1123 C–C ring bend, C–H ring bend
1120 1220 HN–C ring bend, C–H ring bend
1283–1250 1272 C–C ring stretch
1332–1310 1299 C–C ring bend
1353 1332 C–H aliphatic bend
1427 1423 C–H aliphatic stretch
1506 1504 N–H bend
159 –1565 1534–15 0 ri end, C–H aliphatic stretch
1643 1652 = sy stretch
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Table 3. Cont.
Experimental Calculated Assignment
6-chloro-7-propargylamine-5,8-quinolinedione 2a
1700
1680 1695 C=O asym stretch, N–H bend
2113 2145 C≡C stretch
2957 2964 C–H aliphatic stretch
3085–3038 3109–3064 C–H ring stretch
3190 3354 C≡CH stretch
7-chloro-6-propargylamine-5,8-quinolinedione 3a
595 611–580 C–C aliphatic bend
657 657 C≡C–H bend
749–681 725–687 C–C ring stretch, C–H ring stretch
832–807 806 C–Cl bend
1147–1076 1182–1091 C–C ring bend, C–H ring bend
1207 1224 HN–C ring bend, C–H ring bend
1269 1261 C–C ring stretch
1324–1310 1293 C–C ring bend
1346 1331 C–H aliphatic bend
1419 1407 C–H aliphatic stretch
1461 1438 C–H ring bend, C–C ring bend
1517 1503 N–H bend
1597–1569 1584–1551 C–H ring bend, C–H aliphatic stretch
1682 1664 C=O sym stretch, N–H bend
1692 1679 C=O asym stretch
2119 2143 C≡C stretch
2996 2965 C–H aliphatic stretch
3168–3058 3108–3030 C–H ring stretch
3250 3354 C≡CH stretch
3271 3399 N–H stretch
In Figure 6, the experimental and calculated IR spectra in the range of the carbonyl bands
~1600–1750 cm−1 are exposed. Each molecule of 2a and 3a possess two carbonyl groups in the para
position. Stretching vibrations of two carbonyl groups are usually coupled into two vibrations located
at different frequencies, i.e., asymmetric (out of phase) νas at higher frequency and symmetric (in
phase) νs at lower frequency (see Table 3).
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Furthermore, for the 7-substituted derivative, the N–H bending is involved in the νas carbonyl 
stretching, while for the 6-substituted derivative, the N–H bending is involved in the νs carbonyl 
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quinolinedione derivatives described previously by Jastrzebska et al. [25]. As in this case, the C=O 
stretching and the N–H bending vibrations showed coupling effect if they were positioned in close 
proximity within the molecule. Moreover, there is a correlation between the frequency separation  
Figure 6. Experimental (red line) and calculated (black line) IR spectra showing carbonyl bands for
(a) 6-chloro-7-propargylamine-5,8-quinolinedione 2a; and (b) 7-chloro-6-propargyl-5,8-quinolinedione 3a.
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Analysis of the calculated spectra revealed the band νas is attributed mainly to the carbonyl
vibration at the C-8 atom, whereas the νs band is attributed to the C=O vibrations at the C-5
atom. Furthermore, for the 7-substituted derivative, the N–H bending is involved in the νas
carbonyl stretching, while for the 6-substituted derivative, the N–H bending is involved in the νs
carbonyl vibrations. A very similar situation occurred for the 6- and 7-propylamine-substituted
5,8-quinolinedione derivatives described previously by Jastrzebska et al. [25]. As in this case, the C=O
stretching and the N–H bending vibrations showed coupling effect if they were positioned in close
proximity within the molecule. Moreover, there is a correlation between the frequency separation
∆ν = νas − νs of the carbonyl bands and the position of the substituent, i.e., the 7-substituted
derivative shows higher value of ∆ν than the 6-substituted one. For the 7-propargylamine-substituted
5,8-quinolinedione the calculated and experimental separation values ∆ν are 57 cm−1 and 43 cm−1
versus 10 cm−1 and 15 cm−1 for the 6-substituted derivative, respectively (see Table 3). The similar
situation occurred in the case of the 7- and 6-propylamine-substituted 5,8-quinolinediones described
previously [25], for which the ∆ν were 59 cm−1 and 51 cm−1 versus 31 cm−1 and 7 cm−1 for the 7- and
6-substituted derivatives, respectively.
For the 7-propargylamino-5,8-quinolinedione 2a, the νas stretching band shows two peaks at 1700
and 1680 cm−1 (see Figure 5), while for the 6-substituted derivative 3a only single peak at 1692 cm−1
is observed. This effect can be due to the formation of the bifurcated H-bond N2–H2N···O1···H9A–C9
described in the previous subsection. The N–H group of the propargylamine chain is involved in
both the bifurcated H-bond and the νas carbonyl stretching vibrations at the C-8 atom. It is also worth
noting that the observed splitting into two peaks at 1700 and 1680 cm−1 for the νas stretching band
of the 7-substituted derivative is probably not associated with the type of interaction with the D-H
system, but originates rather from the νas distinctive characteristics.
The bifurcated H-bond also strongly influences the N–H stretching vibrations, giving two peaks
at the 3315 and 3258 cm−1. For the 6-substituted propargylamine derivative, the bifurcated H-bond is
absent giving only single band at 3250 cm−1 due to the N–H stretching vibrations.
2.4. Antiproliferative Activity
Compounds 1, 2a–e and 3a–e were tested for the antiproliferative activity in vitro against
the three human cancer cell lines: melanoma (C-32), glioblastoma (SNB-19) and breast cancer (T47D).
Results of the analysis have been summarized in Table 4.
Table 4. Cytotoxic activity of 6,7-dichloro-5,8-quinolinedione 1, amine derivatives of 5,8-quinolinedione
2–3 and cisplatin as a reference compound.
Compound
Cytotoxic Activity IC50 (µg/mL)
C-32 SNB-19 T47D
1 42.48 ± 2.02 2.77 ± 0.07 8.26 ± 0.32
2a 0.61 ± 0.02 0.26 ± 0.02 8.50 ± 0.54
2b 0.75 ± 0.05 0.97 ± 0.01 9.22 ± 0.77
2c 0.67 ± 0.01 0.98 ± 0.01 9.14 ± 0.77
2d 0.63 ± 0.02 0.88 ± 0.05 9.03 ± 0.10
2e 0.64 ± 0.03 0.50 ± 0.04 8.54 ± 0.41
3a 0.58 ± 0.03 0.09 ± 0.01 1.01 ± 0.05
3b 0.67 ± 0.05 0.44 ± 0.01 8.48 ± 0.55
3c 0.65 ± 0.05 0.92 ± 0.07 4.57 ± 0.62
3d 0.61 ± 0.03 0.79 ± 0.03 7.07 ± 0.28
3e 0.64 ± 0.01 0.28 ± 0.05 3.05 ± 5.65
cisplatin 1.51 ± 0.49 0.79 ± 0.07 62.65 ± 2.70
It is seen that introduction of the alkynyl, allyl and propyl chains at the C-7 or C-6 position
leads to an increase in the cytotoxic activity for the (C-32) and (SNB-19) cell lines in comparison to
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the 6,7-dichloro-5,8-quinolinedione 1. Furthermore, the acetylenic amine derivatives 2a–c and 3a–c
show higher activity than the reference compound cisplatin against the C-32 and T47D cell lines.
All amino derivatives of the 5,8-quinolinedione show high cytotoxic activity against the melanoma
(C-32) cell line, with the IC50 varying in the range 0.58 to 0.75 µg/mL. Comparing the activity of
compounds with alkane (2e and 3e), alkene (2d and 3d) and alkyne (2a and 3a) moiety, showed that
the cytotoxic of derivatives depends on the type of bond in the substituent; the rank order of activity
against the C-32 cell line, is as follows: propargyl > allyl > propyl. Moreover, for the other cell line
(SNB-19 and T47D) the highest activity showed propargylamino compounds 2a and 3a. The activity of
3a and 2a against the glioblastoma (SNB-19) cell line for which the IC50 parameters have the lowest
values 0.09 ± 0.01 µg/mL and 0.26 ± 0.02 µg/mL, respectively. These results suggested that the triple
bond seems to be essential for anticancer activity.
For compounds with the acetylenic amine substituents, the cytotoxic activity against
the melanoma (C-32) and the breast cancer (T47D) cell lines follows the order: N-methylpropargylamine
< 1,1-dimethylpropargylamine < propargylamine. As one can see, expansion of the acetylenic amine
chain by binding methyl groups gives a reduction of the cytotoxic activity.
3. Materials and Methods
3.1. General Techniques
Melting points were measured in the open capillary tubes on a Boetius melting point apparatus.
NMR spectra (600/150 MHz) were registered on a Bruker Avance 600 spectrometer (Bruker, Billerica,
MA, USA). The spectra were recorded for 1H and 13C NMR at room temperature. Chemical shifts
were reported in ppm (ν) and J values in Hz. Multiplicity was designated as the singlet (s), doublet (d),
triplet (t) and multiplet (m). High-resolution mass spectral analysis was carried out on a Bruker
Impact II instrument (Bruker, Billerica, MA, USA) The infrared spectra (IR) were registered using
the IRAffinity 1 spectrometer (Shimadzu, Japan) and the KBr pellet method for the sample preparation.
All spectra were recorded in the range of 400–4000 cm−1 at room temperature. TLC was carried out on
silica gel plates (Merck, Darmstadt, Germany) using a mixture of chloroform and ethanol as an eluent.
The visualization was accomplished with UV light and iodine vapour. Column chromatography was
performed on silica gel (Merck) with the mixture of chloroform and ethanol (40:1, v/v) as an eluent.
3.2. Chemistry
The 6,7-dichloro-5,8-quinolinedione 1 was synthesized from the 8-hydroxyquinoline according to
the method described in the literature [12].
Synthesis of the 6-chloro-7-substituted-5,8-quinolinediones 2a–e and 7-chloro-6-substituted-5,8-
quinolinediones 3a–e was as follows:
Synthesis was carried out using the procedure previously described by Kadela et al. [8,9,25].
Briefly, the 6,7-dichloro-5,8-quinolinedione 1 (0.1 g, 0.441 mmol) was dissolved in dry tetrahydrofuran
(1 mL). Next, the potassium carbonate (0.061 g, 0.441 mmol) and corresponding amine (0.441 mmol)
were added to the mixture. After 3 h of stirring at room temperature, the solvent was removed under
reduced pressure. The residue was purified by the column chromatography (CHCl3/EtOH, 40:1 v/v)
to give pure products 2 and 3.
6-chloro-7-propargylamine-5,8-quinolinedione 2a Yield 68%; mp 140–142 ◦C; 1H NMR (CDCl3, 600 MHz)
δ 2.42 (t, J = 2.4 Hz, 1H, CH), 4.68 (dd, J = 2.4 Hz, 2H, CH2), 6.19 (t, 1H, NH), 7.68 (dd, J23 = 4.8 Hz,
J34 = 7.8 Hz, 1H, H-3), 8.47 (dd, J24 = 1.8 Hz, J34 = 7.8 Hz, 1H, H-4), 8.96 (dd, J24 = 1.8 Hz, J23 = 4.8 Hz,
1H, H-2). 13C NMR (CDCl3, 150 MHz) δ ppm: 35.1 (CH2), 73.8 (C≡CH), 78.8 (C≡CH), 128.4 (C-6),
129.5 (C-3), 129.7 (C-4a), 134.8 (C-4), 143.9 (C-7), 145.9 (C-8a), 153.7 (C-2), 165.4 (C-8), 178.4 (C-5).
IR (KBr) νmax (cm−1) 3315–3258 (N–H), 3190–3038 (C–H), 2113 (C≡C), 1700 (C=O), 1643 (C=O),
1599–1565 (C–H). HRMS (APCI) m/z 247.0265 (calcd for C12H8ClN2O2, 247.0274).
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6-chloro-7-(N-methylpropargylamine)-5,8-quinolinedione 2b Yield 61%; mp 130–132 ◦C; 1H NMR (CDCl3,
600 MHz) δ 2.38 (t, J = 2.4 Hz, 1H, CH), 3.32 (s, 3H, CH3), 4.33 (d, J = 2.4 Hz, 2H, CH2), 7.65 (dd,
J23 = 4.8 Hz, J34 = 7.8 Hz, 1H, H-3), 8.46 (dd, J24 = 1.8 Hz, J34 = 7.8 Hz, 1H, H-4), 8.97 (dd, J24 = 1.8 Hz,
J23 = 4.8 Hz, 1H, H-2); 13C NMR (CDCl3, 150 MHz) δ 41.8 (CH2), 44.8 (CH3), 73.5 (C≡CH), 78.6 (C≡CH),
123.2 (C-6), 128.4 (C-3), 128.4 (C-4a), 134.6 (C-4), 147.1 (C-8a), 150.7 (C-7), 154.2 (C-2), 177.2 (C-8),
180.1 (C-5); IR (KBr) νmax (cm−1) 3360–3280 (N–H), 3036–2855 (C–H), 2117 (C≡C), 1692 (C=O),
1680 (C=O), 1588–1558 (C–H). HRMS (APCI) m/z 261.0420 (calcd for C13H10ClN2O2, 261.0431).
6-chloro-7-(1,1-dimethylpropargylamine)-5,8-quinolinedione 2c Yield 58%; mp 156–157 ◦C; 1H NMR (CDCl3,
600 MHz) δ 1.88 (s, 6H, CH3, CH3), 2.45 (t, J = 2.4 Hz, 1H, CH), 6.03 (s, 1H, NH), 7.66 (dd, J23 = 4.8 Hz,
J34 = 7.8 Hz, 1H, H-3), 8.46 (dd, J24 = 1.8 Hz, J34 = 7.8 Hz, 1H, H-4), 8.95 (dd, J24 = 1.8 Hz, J23 = 4.8 Hz, 1H,
H-2); 13C NMR (CDCl3, 150 MHz) δ 29.7 (CH3), 32.8 (CH3), 51.1 (NHC), 72.3 (C≡CH), 86.6 (C≡CH),
126.1 (C-6), 128.1 (C-3), 129.1 (C-4a), 134.6 (C-4), 145.6 (C-8a), 146.4 (C-7), 153.7 (C-2), 176.0 (C-8),
178.5 (C-5); IR (KBr) νmax (cm−1) 3367–3241 (N–H), 2926–2871 (C–H), 2113 (C≡C), 1700 (C=O),
1683 (C=O), 1653–1635 (C–H). HRMS (APCI) m/z 275.0577 (calcd for C14H12ClN2O2, 275.0587).
6-chloro-7-allylamine-5,8-quinolinedione 2d Yield 65%; mp 122–123 ◦C; 1H NMR (CDCl3, 600 MHz) δ
4.53 (dt, J = 1.2 Hz, J = 6.0 Hz, 2H, NHCH2), 5.30 (dt, J = 1.2 Hz, J = 9.0 Hz, 2H, CH=CH2), 6.00 (m,
1H, CH=CH2), 6.25 (s, 1H, NH), 7.66 (dd, J23 = 4.8 Hz, J34 = 7.8 Hz, 1H, H-3), 8.48 (dd, J24 = 1.8 Hz,
J34 = 7.8 Hz, 1H, H-4), 8.93 (dd, J24 = 1.8 Hz, J23 = 4.8 Hz, 1H, H-2); 13C NMR (CDCl3, 150 MHz) δ
47.2 (NHCH2), 117,9 (CH=CH2), 128.2 (C-6), 128.3 (C-3), 129.7 (C-4a), 134.7 (CH=CH2), 135.6 (C-4),
144.4 (C-8a), 146.8 (C-7), 155.4 (C-2), 176.3 (C-8), 178.8 (C-5); IR (KBr) νmaxx (cm−1) 3304 (N–H),
2957–2854 (C–H), 1693 (C=O), 1680 (C=O), 1598–1560 (C–H); HRMS (APCI) m/z 261.0425 (calcd for
C12H10ClN2O2, 249.0431).
7-chloro-6-propargylamine-5,8-quinolinedione 3a Yield 19%; mp 140–142 ◦C; 1H NMR (CDCl3, 600 MHz)
δ 2.37 (t, J = 2.4 Hz, 1H, CH), 4.67 (dd, J = 2.4 Hz, 2H, CH2), 6.01 (t, 1H, NH), 7.62 (dd, J23 = 4.8 Hz,
J34 = 7.8 Hz, 1H, H-3), 8.37 (dd, J24 = 1.8 Hz, J34 = 7.8 Hz, 1H, H-4), 9.03 (dd, J24 = 1.8 Hz, J23 = 4.8 Hz,
1H, H-2); 13C NMR (CDCl3, 150 MHz) δ 35.1 (CH2), 73.7 (C≡CH), 78.9 (C≡CH), 126.8 (C-6), 130.2 (C-3),
131.0 (C-4a), 133.7 (C-4), 143.1 (C-7), 148.0 (C-8a), 155.3 (C-2), 165.4 (C-8), 179.7 (C-5); IR (KBr)
νmax (cm−1) 3271 (N–H), 3250–3058 (C–H), 2119 (C≡C), 1692 (C=O), 1682 (C=O), 1597–1569 (C–H);
HRMS (APCI) m/z 247.0263 (calcd for C12H8ClN2O2, 247.0274).
7-chloro-6-(N-methylpropargylamine)-5,8-quinolinedione 3b Yield 21%; mp 126–127 ◦C; 1H NMR (CDCl3,
600 MHz) δ 2.39 (t, J = 2.4 Hz, 1H, CH), 3.31 (s, 3H, CH3), 4.29 (d, J = 2.4 Hz, 2H, CH2), 7.63 (dd,
J23 = 4.8 Hz, J34 = 7.8 Hz, 1H, H-3), 8.38 (dd, J24 = 1.8 Hz, J34 = 7.8 Hz, 1H, H-4), 9.01 (dd, J24 = 1.8 Hz,
J23 = 4.8 Hz, 1H, H-2); 13C NMR (CDCl3, 150 MHz) δ 41.7 (CH2), 44.7 (CH3), 73.4 (C≡CH), 78.8 (C≡CH),
125.3 (C-7), 127.2 (C-3), 129.7 (C-4a), 135.0 (C-4), 147.2 (C-8a), 149.5 (C-6), 155.3 (C-2), 176.6 (C-8),
181.3 (C-5); IR (KBr) νmax (cm−1) 3175 (N–H), 2927–2854 (C–H), 2107 (C≡C), 1674 (C=O), 1592–1520;
HRMS (APCI) m/z 261.0422 (calcd for C13H10ClN2O2, 261.0431).
7-chloro-6-(1,1-dimethylpropargylamine)-5,8-quinolinedione 3c Yield 16%; mp 148–149 ◦C; 1H NMR (CDCl3,
600 MHz) δ 1.86 (s, 6H, CH3, CH3), 2.44 (t, J = 2.4 Hz, 1H, CH), 5.85 (s, 1H, NH), 7.61 (dd, J23 = 4.8 Hz,
J34 = 7.8 Hz, 1H, H-3), 8.39 (dd, J24 = 1.8 Hz, J34 = 7.8 Hz, 1H, H-4), 9.02 (dd, J24 = 1.8 Hz, J23 = 4.8 Hz, 1H,
H-2); 13C NMR (CDCl3, 150 MHz) δ 29.5 (CH3), 32.7 (CH3), 51.3 (NHC), 72.2 (C≡CH), 86.5 (C≡CH),
127.4 (C-7), 128.2 (C-3), 129.0 (C-4a), 134.4 (C-4), 145.5 (C-8a), 147.5 (C-6), 153.5 (C-2), 177.1 (C-8),
182.1 (C-5); IR (KBr) νmax (cm−1) 3316 (N–H), 3154–2963 (C–H), 2100 (C≡C), 1685 (C=O), 1653 (C=O),
15989–1560 (C–H); HRMS (APCI) m/z 275.0575 (calcd for C14H12ClN2O2, 275.0587).
7-chloro-6-allylamine-5,8-quinolinedione 3d Yield 20%, mp 139–141 ◦C. 1H NMR (CDCl3, 600 MHz) δ
4.51 (dt, J = 1.2 Hz, J = 6.0 Hz, 2H, NHCH2), 5.29 (dt, J = 1.2 Hz, J = 9.0 Hz, 2H, CH=CH2), 5.99 (m,
1H, CH=CH2), 6.15 (s, 1H, NH), 7.59 (dd, J23 = 4.8 Hz, J34 = 7.8 Hz, 1H, H-3), 8.67 (dd, J24 = 1.8 Hz,
J34 = 7.8 Hz, 1H, H-4), 9.01 (dd, J24 = 1.8 Hz, J23 = 4.8 Hz, 1H, H-2); 13C NMR (CDCl3, 150 MHz) δ
47.2 (NHCH2), 117,8 CH=CH2), 126.5 (C-7), 126.8 (C-3), 129.7 (C-4a), 134.8 (CH=CH2), 134.6 (C-4),
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147.4 (C-8a), 148.4 (C-6), 155.3 (C-2), 178.3 (C-8), 180.0 (C-5); IR (KBr) νmax (cm−1) 3321 (N–H),
3080–2926 (C–H), 1683 (C=O), 1647 (C=O), 1602–1559 (C–H); HRMS (APCI) m/z 261.0424 (calcd for
C12H10ClN2O2, 249.0431).
6-chloro-7-propylamine-5,8-quinolinedione 2e and 6-chloro-7-propylamine-5,8-quinolinedione
3e: the spectral data were previously described in the literature [25].
3.3. X-ray Diffraction
The single crystal X-ray experiment was carried out for the following two compounds:
6-chloro-7-propargylamine-5,8-quinolinedione 2a and 7-chloro-6-propargylamine-5,8-quinolinedione
3a, at 100.0(1) K. Single crystals of both compounds were preselected under microscope. The crystals
were installed on a glass capillary and cooled down by Cryostream Cooler (Oxford Cryosystems Ltd,
Oxford, UK). Data sets were collected using an Oxford Diffraction κ diffractometer with a Sapphire3
CCD detector (Oxford Diffraction Ltd., Yarnton, UK). For the integration of the collected data,
the CrysAlis RED software (version 1.171.32.29, Agilent Technologies) was applied. The crystal
structures were solved using direct methods with the SHELXS-97 software. The solutions were refined
using SHELXL-97, SHELXS-2014, and SHELXL-2014/6 programs [29].
The supplementary crystallographic data for 2a and 3a were deposited at the Cambridge
Crystallographic Data Centre (CCDC) as CCDC-1047971 and CCDC-104797. These data can be
obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif.
3.4. Density Functional Theory (DFT) Analysis
Harmonic vibrational spectra were calculated by the DFT method implemented in the Gaussian09
software package [30]. Details have been described in the earlier work [25]. Briefly, the ground
state molecular structure was optimized in silico using the B3LYP exchange-correlation functional
with the 6-31+G(d,p) basis set. The initial molecular structures of compounds 2a and 3a were
taken from the X-ray crystallographic data. The obtained harmonic frequencies were scaled by
a factor of 0.964 in accordance with [31]. Calculated vibrational modes were also analyzed using
the GaussView 5.0 visualization software (Gaussian, Inc., Wallingford, CT, USA). The effect of
the position of 6- and 7-propargylamine chain on carbonyl vibrations was observed by taking into
account the displacement vectors.
3.5. Antiproliferative Assay In Vitro
3.5.1. Cell Culture
All compounds 1, 2a–e and 3a–e were screened for antiproliferative activity using three cultured
cell lines: SNB-19 (human glioblastoma, DSMZ-German Collection of Microorganisms and Cell
Cultures, Braunschweig, Germany), C-32 (human amelanotic melanoma, ATCC-American Type
Culture Collection, Manassas, VA, USA) and T47D (human ductal breast epithelial tumor cell line,
ATCC, Manassas, VA, USA). The cultured cells were kept at 37 ◦C in the 5% CO2 atmosphere. The cells
were seeded (1 × 104 cells/well/100 µL Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum (FCS), streptomycin and penicillin) using the 96-well plates (Corning Inc.,
Corning, NY, USA).
3.5.2. Analysis of Antiproliferative Activity
The cytotoxic activities of tested compounds were determined using the Cell Proliferation
Reagent WST-1 assay (Roche Diagnostics, Mannheim, Germany). The entire procedure was previously
described in detail in an earlier work [8]. Cells were exposed to tested compounds for 24 h at indicated
concentrations (in the rank of 0.1–100 µg/mL of dimethyl sulfoxide (DMSO)), and their viabilities were
quantified using a cell proliferation assay. The WST-1-formazan was detected using a microplate reader
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at 450 nm with the reference wavelength of 600 nm. Results were expressed as a mean value of at least
three independent experiments performed in triplicate. The cytotoxic activity of the tested compound
was compared to the cisplatin. The experiments were repeated in triplicate for each concentration
of the compound. The IC50 parameter describes the concentration of compound (in µg/mL) that
inhibits the proliferation rate of the tumor cells by 50% as compared to the control untreated cells.
Calculation of the IC50 was performed using the GraphPad Prism 6 software (GraphPad Software,
San Diego, CA, USA).
4. Conclusions
New 6- and 7-propargylamine-substituted 5,8-quinolinediones were synthesized and examined
using the X-ray diffraction and IR spectroscopy supplemented by the density functional theory (DFT)
calculations. Different positions of the propargylamine chain influenced crystal structure and formation
of H-bonds. It was found that the H-bond distinctly affected the νas stretching band of the carbonyl
groups only for the 7-propargylamine-substituted 5,8-quinolinedione.
Substantial changes in the frequency separation ∆ν of the carbonyl stretching bands for different
positions of the propargylamine chain were found. Higher frequency separation ∆ν corresponds to
the 7-substituted derivative. Correlation between the ∆ν and position of substituent may provide
an opportunity to use the IR spectroscopy to study substitution reaction.
Cytotoxic activities against three human cancer cell lines for the 5,8-quinolinedione
derivatives with different amine substituents, i.e., propargylamine, N-methylpropargylamine,
1,1-dimethylpropargylamine, allylamine and propylamine were analyzed with respect to their
molecular structure. It was found that introduction of the acetylenic, allyl and propylamine chains
at the C-7 or C-6 position led to an increase in the cytotoxic activity for the melanoma and
glioblastoma cell lines in comparison to the starting compound 6,7-dichloro-5,8-quinolinedione 1.
Furthermore, for the melanoma (C-32) and breast cancer (T47D) cell lines, the acetylenic amine
derivatives showed higher activity than the reference compound cisplatin. The low IC50 values
for the 7- and 6-substituted propargylamine derivatives against the glioblastoma (SNB-19) cell line
were observed.
Supplementary Materials: The following are available online at www.mdpi.com/2073-4352/7/1/15/s1. Table S1:
Selected geometric parameters given by X-ray diffraction experiment and theoretical calculations for compounds
2a and 3a. Figure S1: 6-chloro-7-propargylamine-5,8-quinolinedione 2a, (a) 1H NMR spectrum, (b) 13C NMR
spectrum, (c) IR spectrum. Figure S2: 6-chloro-7-(N-methylpropargylamine)-5,8-quinolinedione 2b, (a) 1H NMR
spectrum, (b) 13C NMR spectrum, (c) IR spectrum. Figure S3: 6-chloro-7-(1,1-dimethylpropargylamine)-
5,8-quinolinedione 2c, (a) 1H NMR spectrum, (b) 13C NMR spectrum, (c) IR spectrum. Figure S4: 6-chloro-7-
allylamine-5,8-quinolinedione 2d, (a) 1H NMR spectrum, (b) 13C NMR spectrum, (c) IR spectrum. Figure S5:
7-chloro-6-propargylamine-5,8-quinolinedione 3a, (a) 1H NMR spectrum, (b) 13C NMR spectrum, (c) IR spectrum.
Figure S6: 7-chloro-6-(N-methylpropargylamine)-5,8-quinolinedione 3b, (a) 1H NMR spectrum, (b) 13C NMR
spectrum, (c) IR spectrum. Figure S7: 7-chloro-6-(1,1-dimethylpropargylamine)-5,8-quinolinedione 3c, (a) 1H NMR
spectrum, (b) 13C NMR spectrum, (c) IR spectrum. Figure S8: 7-chloro-6-allylamine-5,8-quinolinedione
3d, (a) 1H NMR spectrum, (b) 13C NMR spectrum, (c) IR spectrum. Figure S9: The crystal packing of
6-chloro-7-propargylamine-5,8-quinolinedione 2a. View along axis “b”. Figure S10: The crystal packing of
7-chloro-6-propargylamine-5,8-quinolinedione 3a. View along axis “b”.
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